Search results for "Complications."

showing 10 items of 1514 documents

Postoperative Repositioning of Inverted Descemet Membrane Endothelial Keratoplasty Grafts

2019

Item does not contain fulltext PURPOSE: To present 4 cases of postoperative repositioning of inverted grafts after Descemet membrane endothelial keratoplasty (DMEK). METHODS: Retrospective case reports of 4 patients presenting with subtotal to total graft detachment after DMEK, most probably owing to upside-down graft positioning. Graft repositioning was performed 1 to 14 days after initial DMEK surgery. In 3 cases (cases 1, 3, and 4), repositioning was performed without removing the graft from the anterior chamber (AC), whereas for case 2, the graft had to be removed from the AC to attain correct graft orientation. RESULTS: In all 4 cases, the initially upside-down DMEK grafts could be suc…

Graft RejectionMaleReoperationmedicine.medical_specialtyDescemet membraneClear corneasSensory disorders Donders Center for Medical Neuroscience [Radboudumc 12]Corneal Diseases03 medical and health sciences0302 clinical medicinePostoperative ComplicationsCorneal edemaOphthalmologyCorneamedicineHumansDescemet MembraneAgedRetrospective StudiesAged 80 and overbusiness.industryMiddle AgedEndothelial cell densityOphthalmologymedicine.anatomical_structuresurgical procedures operative030221 ophthalmology & optometryFemalebusiness030217 neurology & neurosurgeryDescemet Stripping Endothelial KeratoplastyCornea. the Journal of Cornea and External Disease
researchProduct

Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation

2013

Introduction. Combined liver-kidney transplantation (LKT) is the best therapeutic option for patients with end-stage liver and kidney disease. Objectives. To analyze baseline characteristics and clinical outcome of LKT compared to isolated liver transplantation (LT). Material and methods. The study included 16 LKT performed between 1998 and 2006 and 32 LT matched by age, sex, date and indication for transplantation. Demographic, pretransplant, post-transplant and survival variables were analyzed. Results. As planned by the study design, mean age, distribution by sex and indication for LT were similar between groups. The most common indication for LT was HCV- and/or alcohol-induced cirrhosis…

Graft RejectionMaleTime FactorsCirrhosismedicine.medical_treatmentSpecialties of internal medicineKaplan-Meier EstimateLiver transplantationGastroenterologyKidney transplantationchemistry.chemical_compoundMetabolic complicationsRisk FactorsKidney transplantationOutcomeBacterial InfectionsGeneral MedicineMiddle AgedSurvival RateTreatment OutcomeRC581-951CreatinineHepatocellular carcinomaHypertensionFemaleAdultReoperationmedicine.medical_specialtyAdolescentPostoperative HemorrhageEnd Stage Liver DiseaseRenal DialysisDiabetes mellitusInternal medicinemedicineHumansArterial PressureDialysisAgedCreatinineChi-Square DistributionLiver transplantationHepatologyurogenital systembusiness.industrymedicine.diseaseSurgeryTransplantationchemistryCase-Control StudiesKidney Failure ChronicbusinessBiomarkers
researchProduct

Obstetric and Neonatal Outcome of Pregnancies Fathered by Males on Immunosuppression After Solid Organ Transplantation

2015

Immunosuppressive drugs may influence spermatogenesis, but little is known about outcome of pregnancies fathered by transplanted males. We estimated risk of adverse outcomes in pregnancies (with data after the first trimester) fathered by males that had undergone organ transplantation and were treated with immunosuppression. A population-based study, linking data from the Norwegian transplant registry and the Medical Birth Registry of Norway during 1967-2009 was designed. All Norwegian men undergoing solid organ transplantation were included. Odds ratios for major malformations, preeclampsia, preterm delivery (<37 weeks) and small-for-gestational-age were obtained using logistic regression.…

Graft RejectionMaleimmunosuppressantmedicine.medical_treatmentOrgan transplantationCohort StudiesFathersPre-EclampsiaObstetrics and gynaecologyPregnancyRisk FactorsImmunology and AllergyPharmacology (medical)Registrieseducation.field_of_studyNorwayObstetricsPregnancy OutcomeImmunosuppressionMiddle Agedpracticesurgical procedures operativePremature BirthFemalepregnancyImmunosuppressive AgentsLung TransplantationAdultmedicine.medical_specialtyAdolescentPopulationCongenital AbnormalitiesPreeclampsiaYoung AdultmedicineHumansSpermatogenesiseducationRetrospective Studiesobstetrics and gynecologyTransplantationPregnancybusiness.industryOrgan TransplantationOdds ratiomedicine.diseasehealth services and outcomes researchKidney TransplantationLiver TransplantationSurgeryPregnancy ComplicationsTransplantationclinical researchHeart Transplantationbusiness
researchProduct

Donor/recipient algorithm for management of the middle hepatic vein in right graft live donor liver transplantation

2010

Abstract Background The aim of this study was to delineate an algorithm for donor and recipient criteria and middle hepatic vein (MHV) management in right-graft live-donor liver transplantation (LDLT) on the basis of computerized 3-dimensional computed tomographic image analysis. Methods Data on 94 consecutive right-graft LDLTs were prospectively collected. Graft and remnant data for the first 23 cases were retrospectively evaluated by means of 3-dimensional computed tomographic reconstructions, and on the basis of that preliminary series, a graft selection algorithm using 3 parameters—hepatic vein dominance classification, graft and remnant graft volume/body weight ratios, and congestion v…

Graft RejectionMalemedicine.medical_specialtyTissue and Organ ProcurementLive donormedicine.medical_treatmentHepatic VeinsLiver transplantationliverBody weightRisk AssessmentPreoperative careComputed tomographicCohort StudiesImaging Three-DimensionalPostoperative ComplicationsPreoperative CareLiving DonorsmedicineGraft selectionHepatectomyHumansProspective StudiesAnalysis of VarianceSmall for size syndromebusiness.industryPatient SelectionGraft SurvivalGeneral MedicineLiver TransplantationSurgeryTreatment Outcomesurgical procedures operativeMathematikFemaleSurgeryHepatectomyTomography X-Ray ComputedbusinessAlgorithmAlgorithmsFollow-Up StudiesLiver CirculationThe American Journal of Surgery
researchProduct

Successful treatment of HSV encephalitis during pregnancy.

1989

A propos d'une femme presentant une grossesse de 23 semaines. Description des signes cliniques et electroencephalographiques. Les effets de l'aciclovir sur l'encephalite et sur l'evolution de la grossesse sont etudies

GynecologyAdultPregnancymedicine.medical_specialtyChemotherapybusiness.industrymedicine.medical_treatmentAcyclovirHerpes Simplexmedicine.diseasePregnancyImmunologymedicineGestationEncephalitisHumansFemaleNeurology (clinical)AciclovirHsv encephalitisPregnancy Complications InfectiousbusinessEncephalitismedicine.drugNeurology
researchProduct

UROEPITHELIAL DEFENSE IN CHILDREN WITH URINARY TRACT INFECTIONS (UTI)

1985

It is well accepted that obstructive uropathy causes UTI.In patients without urological anomalies a host defense defect of the uroepithelial cells (UEC) may result in increased susceptibility to bacterial infections.Even in patients with vesicourethral reflux (VUR) and recurrent UTI the postulated defense mechanism may be impaired since a significant proportion of these patients still suffer from UTI after surgical therapy.Therefore the influence of UEC on bacterial growth was investigated in 5 groups of children: healthy donors,children with neurogenic bladder due to myelomeningocele (MMC),patients with asymptomatic bacteriuria (ABU;without obstructive uropathy) and patients with VUR after…

Gynecologymedicine.medical_specialtybusiness.industryUrinary systemUrologyRefluxUrineurologic and male genital diseasesmedicine.diseasefemale genital diseases and pregnancy complicationsRpmi mediumRECURRENT UTIPediatrics Perinatology and Child HealthmedicineIn patientbusinessObstructive uropathyNeurogenic bladder dysfunctionPediatric Research
researchProduct

Lipid profile during pregnancy in HIV-infected women

2006

Purpose: We investigated the evolution of serum lipid levels in HIV-infected pregnant women and the potential effect of antiretroviral treatment during pregnancy using data from a national surveillance study. Method: Fasting lipid measurements collected during routine care in pregnancy were used, analyzing longitudinal changes and differences in lipid values at each trimester by protease inhibitors (Pls) and stavudine use. Multivariate analyses were used to control for simultaneous factors potentially leading to hyperlipidemia. Study population included 248 women. Results: Lipid values increased progressively and significantly during pregnancy: mean increases between the first and third tri…

HIV InfectionsTriglyceridechemistry.chemical_compoundPregnancyHiv infectedHyperlipidemiaHIV InfectionPharmacology (medical)Pregnancy Complications Infectioustriglyceridesmedicine.diagnostic_testStavudineStavudineHyperlipidemiaInfectious DiseasesTreatment OutcomeItalyPopulation SurveillancePopulation studylipids (amino acids peptides and proteins)FemalePregnancy TrimesterPregnancy TrimesterspregnancyHumanmedicine.drugAdultmedicine.medical_specialtyLogistic Modelprotease inhibitorsHyperlipidemiascholesterol; HIV; pregnancy; protease inhibitors; triglyceridesprotease inhibitorInternal medicinemedicineHumansHIV Protease InhibitorTriglyceridesPregnancyTriglycerideCholesterolbusiness.industryCholesterol HDLcholesterolHIVCholesterol LDLHIV Protease Inhibitorsmedicine.diseaseLipid MetabolismEndocrinologyLogistic ModelschemistryPregnancy Complications InfectiouHIV-1Lipid profilebusiness
researchProduct

Hypoxia inducible factor-1 alpha expression is increased in infected positive HPV16 DNA oral squamous cell carcinoma and positively associated with H…

2011

Abstract Background There is increasing evidence for the role of High Risk (HR) Human PapillomaVirus (HPV) in the pathogenesis of Oral Squamous Cell Carcinoma (OSCC). The E6 and E7 oncogenes from HR HPVs are responsible for the deregulation of p53 and pRB proteins involved in cell cycle and apoptotic pathways. In cell lines experiments, the HPV E7 protein seems to be able to enhance Hypoxia Inducible Factor-1 alpha (HIF-1α) activity, normally involved in the response to hypoxia and able to enhance angiogenesis. Results We studied tumor specimens from 62 OSCC; a higher prevalence of tumors in TNM stage II and also in pT2 class between OSCC infected positive HPV16 DNA than non-infected ones w…

HPV16Cancer ResearchPathologymedicine.medical_specialtyHPVNecrosisAngiogenesisEpidemiologyAlpha (ethology)BiologyOral Squamous Cell Carcinomalcsh:RC254-282lcsh:Infectious and parasitic diseasesPathogenesisHypoxia-Inducible Factor 1-Alphachemistry.chemical_compoundmedicinelcsh:RC109-216E7Oral Squamous Cell Carcinoma Hif-1α HPV HPV16 E7virus diseasesHypoxia (medical)lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensfemale genital diseases and pregnancy complicationsstomatognathic diseasesInfectious DiseaseschemistryOncologyApoptosisCancer researchmedicine.symptomHif-1αDNAResearch ArticleInfectious agents and cancer
researchProduct

A population-based study relevant to seasonal variations in causes of death in children undergoing surgery for congenital cardiac malformations

2007

AbstractAimsOur objectives were, first, to study seasonal distribution of perioperative deaths within 30 days after surgery, and late death, in children undergoing surgery for congenitally malformed hearts, and second, to study the causes of late death.MethodsWe analysed a retrospective cohort of 1,753 children with congenital cardiac malformations born and undergoing surgery in the period from 1990 through 2002 with a special focus on the causes of late death. The data was obtained from the registry of congenital cardiac malformations at Rikshospitalet, Oslo, and the Norwegian Medical Birth Registry. The mean follow-up from birth was 8.1 years, with a range from zero to 15.2 years.ResultsD…

Heart Defects CongenitalMalePediatricsmedicine.medical_specialtyTime FactorsAdolescentrespiratory syncytial virussudden deathSudden deathCohort StudiesPostoperative Complicationsrespiratory infectionCause of DeathVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Pediatrics: 760medicineHumansChildDown's syndromeRetrospective StudiesVDP::Medical disciplines: 700::Clinical medical disciplines: 750::Cardiology: 771Norwaybusiness.industryInfant NewbornInfantRespiratory infectionGeneral MedicinemortalityPeer reviewSurvival RatePopulation based studyChild PreschoolPediatrics Perinatology and Child HealthFemaleSeasonsCardiology and Cardiovascular MedicineCongenital cardiac malformationsbusinessCardiology in the Young
researchProduct

The Association of H1N1 Pandemic Influenza with Congenital Anomaly Prevalence in Europe

2015

BACKGROUND: In the context of the European Surveillance of Congenital Anomalies (EUROCAT) surveillance response to the 2009 influenza pandemic, we sought to establish whether there was a detectable increase of congenital anomaly prevalence among pregnancies exposed to influenza seasons in general, and whether any increase was greater during the 2009 pandemic than during other seasons.METHODS: We performed an ecologic time series analysis based on 26,967 pregnancies with nonchromosomal congenital anomaly conceived from January 2007 to March 2011, reported by 15 EUROCAT registries. Analysis was performed for EUROCAT-defined anomaly subgroups, divided by whether there was a prior hypothesis of…

Heart Septal Defects VentricularPediatricsmedicine.medical_specialtyEpidemiologyEPIDEMICSPrevalenceCRITICAL PERIODSContext (language use)DiseaseILLNESSmedicine.disease_causeTricuspid AtresiaDISEASECongenital AbnormalitiesInfluenza A Virus H1N1 SubtypePregnancyCystic Adenomatoid Malformation of Lung CongenitalInfluenza HumanPandemicPrevalenceInfluenza A virusHumansMedicineNeural Tube DefectsRegistriesPregnancy Complications InfectiousPandemicsTetralogy of FallotRISKPregnancyOUTCOMESbusiness.industryABNORMALITIESInfant NewbornPOLICIESmedicine.diseaseEuropeVaccinationTetralogy of FallotVACCINATIONFemaleTricuspid Valve StenosisbusinessPREGNANT-WOMENEpidemiology
researchProduct